维普中文期刊产品整合服务
9篇 您的检索式:作者名="KALERGIS M"
    题名 作者 年代 出处 被引量
1Canadian dietitians' use and perceptions of glycemic index in diabetes management 显示文摘Kalergis M Pytka E Yale JF 2006Canadian Journal of Dietetic Practice & Research2006,67,1:1
2Canadian dietitians,use and perceptions of glycemic index in diabetes mamagement显示文摘Kalergis M Pytka E Yale JF 2006Can J Diet pract Res2006,67,1:1
3Modula- tion of nuclear factor-kappa B activity can influence the suscepti- bility to systemic lupus erythematosus 显示文摘Kalergis A M Iruretagoyena M I Barrientos M J 2009Immunology2009,128,1:1
4THEMIS,the new kid on the block for T-cell development显示文摘Understanding T-cell development is a major goal of the immunology field and is crucial for the elucidation of the mechanisms behind self-tolerance and the occurrence of autoimmune disorders.T-cell development is a complex process that begins in the bone marrow or fetal liver,where lymphoid progenitors arise.Janyra A Espinoza Evelyn L Jara Alexis M Kalergis 2017Cellular & Molecular Immunology2017,14,9:1
5Canadian dietitians' use and perceptions of glycemic index in diabetes management 显示文摘KALERGIS M PYTKA E YALE J F 2006Can J Diet Pract Res2006,67,1:1
6Inducing tumor immunity through the selective engagement of activating Fc- gamma receptors on dendritic cells显示文摘Kalergis A M Ravetch J V 2002J Exp Med2002,195,12:1
7Modtda- tion of nuclear factor-kappaB activity can influence the susceptibil- ity to systemic lupus erythematosus 显示文摘Kalergis A M Iruretagoyena M I Barrientos M J 2009Immunology2009,128,1:1
8A simplifiedprocedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I显示文摘Kalergis A M Goyarts E C Palmieri E 2000Immunol Methods2000,234,12:1
9Role of Salmonella enterica exposure in Chilean Crohn's disease patients显示文摘AIM:To study the association between exposure toSalmonella enterica(SE)and Crohn’s disease(CD)and its clinical implications in Chilean patients.METHODS:Ninety-four unrelated Chilean CD patients from CAREI(Active Cohort Registry of Inflammatory Bowel Disease)presenting to a single inflammatory bowel disease(IBD)unit of a University Hospital were prospectively included in this study.A complete clinical evaluation,including smoking history,was performed at the initial visit,and all the important data of clinical evolution of CD were obtained.Blood samples from these CD patients and 88 healthy sex-and agematched control subjects were analyzed for exposure to SE and for their NOD2/CARD15 gene status using the presence of anti-Salmonella lipopolysaccharide antibodies[immunoglobulin-G type(IgG)]and polymerase chain reaction(PCR),respectively.We also evaluated exposure to SE in 90 sex-and age-matched patients without CD,but with known smoking status(30 smokers,30 non-smokers,and 30 former smokers).RESULTS:CD patients comprised 54 females and 40males,aged 35.5±15.2 years at diagnosis with a mean follow-up of 9.0±6.8 years.CD was inflammatory in 59 patients(62.7%),stricturing in 24(25.5%)and penetrating in 15(15.5%).Thirty cases(31.9%)had lesions in the ileum,29(30.8%)had ileocolonic lesions,32(34.0%)had colonic lesions and 23(24.4%)had perianal disease.Sixteen CD patients(17%)were exposed to SE compared to 15(17%)of 88 healthy control subjects(P=0.8).Thirty-one CD patients(32.9%)were smokers,and 7(7.4%)were former smokers at diagnosis.In the group exposed to SE,10 of 16 patients(62.5%)were active smokers compared to 21 of 78 patients(26.9%)in the unexposed group(P=0.01).On the other hand,10 of 31 smoking patients(32%)were exposed to SE compared to 5 of 56 nonsmoking patients(9%),and one of the seven former smokers(14%)(P=0.01).In the group of 90 patients without CD,but whose smoking status was known,there was no differ-ence in exposure to SE[3 of 30 smokers(10%),5 of30 non-smokers(16%),and 5 of 30 former smokers(16%);P=0.6].There were no differences in disease severity between CD patients with and those without anti-SE IgG antibodies,estimated as the appearance of stricturing[2(12.5%)vs 22(28.2%);P=0.2]or penetrating lesions[2(12.5%)vs 13(16.6%);P=1.0];or the need for immunosuppressants[11(68.7%)vs 55(70.5%);P=1.0],anti-tumor necrosis factor therapy[1(6.2%)vs 7(8.9%);P=1.0],hospitalization[13(81.2%)vs 58(74.3%);P=0.7],or surgery[3(18.7%)vs 12(15.3%);P=0.3),respectively].No other factors were associated with SE,including NOD2/CARD15 gene status.Seventeen CD patients(18%)had at least one mutation of the NOD2/CARD15 gene.CONCLUSION:Our study found no association between exposure to SE and CD.We observed a positive correlation between SE exposure and cigarette smoking in Chilean patients with CD,but not with disease severity.Manuel Alvarez-Lobos Daniela P Pizarro Christian E Palavecino Abner Espinoza Valentina P Sebastián Juan C Alvarado Patricio Ibaez Carlos Quintana Orlando Díaz Alexis M Kalergis Susan M Bueno 2013World Journal of Gastroenterology2013,19,35:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费